AnaptysBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	248.47	238.2	123.08	35.97	71.31	495.73
Short-Term Investments	37.99	73.44	262.29	354.94	369.93	52.37
Cash & Short-Term Investments	286.46	311.64	385.37	390.9	441.24	548.1
Cash Growth	-15.73%	-19.13%	-1.42%	-11.41%	-19.50%	39.23%
Other Receivables	25.75	33.85	40.77	6.85	1.42	0.88
Total Trade Receivables	25.75	33.85	40.77	6.85	1.42	0.88
Other Current Assets	3.91	4.76	5.74	9.08	4.55	4.9
Total Current Assets	316.11	350.25	431.88	406.84	447.21	553.88
Net Property, Plant & Equipment	13.32	13.89	16.23	18.27	19.99	21.84
Long-Term Investments	-	-	35.47	27.03	142.94	67.1
Other Long-Term Assets	0.26	0.26	0.26	0.26	0.26	0.26
Total Assets	329.68	364.4	483.83	452.39	610.38	643.07
Accounts Payable	7.52	3.87	4	4.7	2.78	1.74
Accrued Expenses	32.07	32.67	39.5	30.97	21.63	12.85
Current Portion of Leases	2.12	2.08	1.93	1.78	1.64	1.51
Total Current Liabilities	41.7	38.63	45.43	37.44	26.05	16.1
Long-Term Leases	11.49	12.03	14.11	16.04	17.81	19.45
Other Long-Term Liabilities	263.74	276.53	353.43	310.81	304.41	251.09
Total Long-Term Liabilities	275.24	288.56	367.54	326.84	322.23	270.54
Total Liabilities	316.94	327.19	412.97	364.29	348.28	286.64
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-in Capital	838.31	809.77	829.86	702.97	717.8	678.58
Accumulated Other Comprehensive Income	-0.15	-0.02	0.31	-0.8	-5.25	-0.42
Retained Earnings	-	-	-759.33	-614.1	-450.48	-321.75
Shareholders' Equity	838.19	809.77	70.87	88.1	262.1	356.43
Total Liabilities & Equity	329.68	364.4	483.83	452.39	610.38	643.07
Total Debt	13.61	14.11	16.04	17.81	19.45	20.96
Net Cash (Debt)	272.84	297.53	369.34	373.09	421.79	527.14
Net Cash Growth	-8.30%	-19.44%	-1.01%	-11.55%	-19.98%	34.03%
Net Cash Per Share	9.26	10.35	13.01	13.86	14.98	19.22
Book Value	838.19	809.77	70.87	88.1	262.1	356.43
Book Value Per Share	28.45	28.16	2.50	3.27	9.31	12.99
Tangible Book Value	838.19	809.77	70.87	88.1	262.1	356.43
Tangible Book Value Per Share	28.45	28.16	2.50	3.27	9.31	12.99

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q